Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
BMC Cancer
Published in: BMC Cancer 1/2021

Open Access 01-12-2021 | Glioma | Correction

Correction to: Nrf2 is required to maintain the self-renewal of glioma stem cells

Authors: Jianhong Zhu, Handong Wang, Qing Sun, Xiangjun Ji, Lin Zhu, Zixiang Cong, Yuan Zhou, Huandong Liu, Mengliang Zhou

Published in: BMC Cancer | Issue 1/2021

Login to get access

Excerpt

Correction to: BMC Cancer 13, 380 (2013) …
Literature
1.
Metadata
Title
Correction to: Nrf2 is required to maintain the self-renewal of glioma stem cells
Authors
Jianhong Zhu
Handong Wang
Qing Sun
Xiangjun Ji
Lin Zhu
Zixiang Cong
Yuan Zhou
Huandong Liu
Mengliang Zhou
Publication date
01-12-2021
Publisher
BioMed Central
Published in
BMC Cancer / Issue 1/2021
Electronic ISSN: 1471-2407
DOI
https://doi.org/10.1186/s12885-021-08338-x

Other articles of this Issue 1/2021

BMC Cancer 1/2021 Go to the issue

Research

Clinicopathological features and prognostic significance of C5aR in human solid tumors: a Meta-analysis

Research article

A retrospective study of CT-guided percutaneous irreversible electroporation (IRE) ablation: clinical efficacy and safety

Research article

The construction and validation of an RNA binding protein-related prognostic model for bladder cancer

Research

Ultrasound-guided implantation of radioactive 125I seed in radioiodine refractory differentiated thyroid carcinoma

Research article

4’-O-Methylbroussochalcone B as a novel tubulin polymerization inhibitor suppressed the proliferation and migration of acute myeloid leukaemia cells

Research

Hotspot mutation profiles of AKT1 in Asian women with breast and endometrial cancers
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits